oa SA Pharmaceutical Journal - Drug alert

Volume 73, Issue 6
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Extracted from text ... SA Pharmaceutical Journal - July 2006 56 DRUG INFO Drug ALERT Food and Drug Administration (FDA) issues a safety alert regarding the use of promethazine hydrochloride in young children Medications containing promethazine hydrochloride (HCl) should not be used for children less than two years of age because of the potential for fatal respiratory depression. This includes promethazine HCl in any form: syrups, suppositories, tablets or injectables. Cases of respiratory depression, including fatalities, have been reported with use of promethazine HCl in children less than two years of age. Caution should also be exercised when administering promethazine HCl in any form ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error